nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Drug fever—Mercaptopurine—Crohn's disease	0.043	0.0456	CcSEcCtD
Cefuroxime—Hepatic impairment—Mesalazine—Crohn's disease	0.0426	0.0453	CcSEcCtD
Cefuroxime—Red blood cell sedimentation rate increased—Mesalazine—Crohn's disease	0.0289	0.0307	CcSEcCtD
Cefuroxime—Drug fever—Mesalazine—Crohn's disease	0.0233	0.0248	CcSEcCtD
Cefuroxime—Stiffness—Mesalazine—Crohn's disease	0.0205	0.0218	CcSEcCtD
Cefuroxime—Cholestasis—Mercaptopurine—Crohn's disease	0.0189	0.0201	CcSEcCtD
Cefuroxime—Vaginal moniliasis—Mesalazine—Crohn's disease	0.0154	0.0164	CcSEcCtD
Cefuroxime—Vulvovaginal candidiasis—Mesalazine—Crohn's disease	0.0148	0.0157	CcSEcCtD
Cefuroxime—Vulvovaginal mycotic infection—Mesalazine—Crohn's disease	0.0142	0.0151	CcSEcCtD
Cefuroxime—Local reaction—Mesalazine—Crohn's disease	0.0141	0.0149	CcSEcCtD
Cefuroxime—Candida infection—Mercaptopurine—Crohn's disease	0.0137	0.0145	CcSEcCtD
Cefuroxime—Nephropathy toxic—Mesalazine—Crohn's disease	0.0136	0.0144	CcSEcCtD
Cefuroxime—Gastrointestinal symptom NOS—Mesalazine—Crohn's disease	0.0132	0.0141	CcSEcCtD
Cefuroxime—Mouth ulceration—Mercaptopurine—Crohn's disease	0.013	0.0138	CcSEcCtD
Cefuroxime—Abdominal cramps—Mesalazine—Crohn's disease	0.0115	0.0122	CcSEcCtD
Cefuroxime—Nephritis interstitial—Mesalazine—Crohn's disease	0.0115	0.0122	CcSEcCtD
Cefuroxime—Liver disorder—Mesalazine—Crohn's disease	0.0114	0.0121	CcSEcCtD
Cefuroxime—Cholestasis—Azathioprine—Crohn's disease	0.0113	0.012	CcSEcCtD
Cefuroxime—Cholestasis—Mesalazine—Crohn's disease	0.0102	0.0109	CcSEcCtD
Cefuroxime—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.0102	0.0108	CcSEcCtD
Cefuroxime—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00868	0.00922	CcSEcCtD
Cefuroxime—Pancytopenia—Mercaptopurine—Crohn's disease	0.00854	0.00908	CcSEcCtD
Cefuroxime—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.00823	0.00874	CcSEcCtD
Cefuroxime—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00823	0.00874	CcSEcCtD
Cefuroxime—Colitis—Azathioprine—Crohn's disease	0.0082	0.00872	CcSEcCtD
Cefuroxime—Aplastic anaemia—Azathioprine—Crohn's disease	0.00802	0.00852	CcSEcCtD
Cefuroxime—Stomatitis—Mercaptopurine—Crohn's disease	0.00782	0.00831	CcSEcCtD
Cefuroxime—Vaginal inflammation—Mesalazine—Crohn's disease	0.00778	0.00827	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.00778	0.00827	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00759	0.00806	CcSEcCtD
Cefuroxime—Colitis—Mesalazine—Crohn's disease	0.00747	0.00794	CcSEcCtD
Cefuroxime—Candida infection—Mesalazine—Crohn's disease	0.00743	0.00789	CcSEcCtD
Cefuroxime—Blood urea increased—Mesalazine—Crohn's disease	0.00735	0.00781	CcSEcCtD
Cefuroxime—Vaginal infection—Mesalazine—Crohn's disease	0.00735	0.00781	CcSEcCtD
Cefuroxime—Aplastic anaemia—Mesalazine—Crohn's disease	0.00731	0.00776	CcSEcCtD
Cefuroxime—Cephaloglycin—SLC22A5—Crohn's disease	0.00717	0.122	CrCbGaD
Cefuroxime—Hepatic function abnormal—Azathioprine—Crohn's disease	0.0071	0.00754	CcSEcCtD
Cefuroxime—Mouth ulceration—Mesalazine—Crohn's disease	0.00704	0.00748	CcSEcCtD
Cefuroxime—Cefepime—SLC22A5—Crohn's disease	0.00679	0.115	CrCbGaD
Cefuroxime—Immune system disorder—Mercaptopurine—Crohn's disease	0.0065	0.00691	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.0065	0.0069	CcSEcCtD
Cefuroxime—Renal impairment—Mesalazine—Crohn's disease	0.00594	0.00631	CcSEcCtD
Cefuroxime—Thirst—Mesalazine—Crohn's disease	0.00594	0.00631	CcSEcCtD
Cefuroxime—Leukopenia—Mercaptopurine—Crohn's disease	0.00561	0.00596	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00559	0.00593	CcSEcCtD
Cefuroxime—Arthralgia—Mercaptopurine—Crohn's disease	0.00534	0.00567	CcSEcCtD
Cefuroxime—Cefixime—SLC22A5—Crohn's disease	0.00531	0.0903	CrCbGaD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0053	0.00563	CcSEcCtD
Cefuroxime—Blood creatinine increased—Mesalazine—Crohn's disease	0.00529	0.00562	CcSEcCtD
Cefuroxime—Pancytopenia—Azathioprine—Crohn's disease	0.00509	0.00541	CcSEcCtD
Cefuroxime—Cramp muscle—Mesalazine—Crohn's disease	0.00509	0.00541	CcSEcCtD
Cefuroxime—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00501	0.00532	CcSEcCtD
Cefuroxime—Ceftazidime—SLC22A5—Crohn's disease	0.00499	0.0849	CrCbGaD
Cefuroxime—Skin disorder—Mercaptopurine—Crohn's disease	0.00497	0.00528	CcSEcCtD
Cefuroxime—Cefdinir—SLC22A5—Crohn's disease	0.0049	0.0833	CrCbGaD
Cefuroxime—Anorexia—Mercaptopurine—Crohn's disease	0.00488	0.00518	CcSEcCtD
Cefuroxime—Eosinophilia—Mesalazine—Crohn's disease	0.00483	0.00514	CcSEcCtD
Cefuroxime—Infestation NOS—Azathioprine—Crohn's disease	0.00478	0.00508	CcSEcCtD
Cefuroxime—Infestation—Azathioprine—Crohn's disease	0.00478	0.00508	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00474	0.00503	CcSEcCtD
Cefuroxime—Bronchitis—Mesalazine—Crohn's disease	0.0047	0.00499	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00466	0.00495	CcSEcCtD
Cefuroxime—Cefradine—SLC22A5—Crohn's disease	0.00466	0.0792	CrCbGaD
Cefuroxime—Pancytopenia—Mesalazine—Crohn's disease	0.00464	0.00493	CcSEcCtD
Cefuroxime—Neutropenia—Mesalazine—Crohn's disease	0.00457	0.00485	CcSEcCtD
Cefuroxime—Dysuria—Mesalazine—Crohn's disease	0.00457	0.00485	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00454	0.00482	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00452	0.0048	CcSEcCtD
Cefuroxime—Agranulocytosis—Azathioprine—Crohn's disease	0.00446	0.00474	CcSEcCtD
Cefuroxime—Decreased appetite—Mercaptopurine—Crohn's disease	0.00445	0.00473	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00442	0.00469	CcSEcCtD
Cefuroxime—Cefadroxil—SLC22A5—Crohn's disease	0.0044	0.0748	CrCbGaD
Cefuroxime—Infestation—Mesalazine—Crohn's disease	0.00435	0.00463	CcSEcCtD
Cefuroxime—Infestation NOS—Mesalazine—Crohn's disease	0.00435	0.00463	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00432	0.00459	CcSEcCtD
Cefuroxime—Haemoglobin—Azathioprine—Crohn's disease	0.00431	0.00458	CcSEcCtD
Cefuroxime—Haemorrhage—Azathioprine—Crohn's disease	0.00429	0.00456	CcSEcCtD
Cefuroxime—Renal failure—Mesalazine—Crohn's disease	0.00428	0.00455	CcSEcCtD
Cefuroxime—Stomatitis—Mesalazine—Crohn's disease	0.00424	0.00451	CcSEcCtD
Cefuroxime—Jaundice—Mesalazine—Crohn's disease	0.00424	0.00451	CcSEcCtD
Cefuroxime—Urinary tract infection—Mesalazine—Crohn's disease	0.00423	0.0045	CcSEcCtD
Cefuroxime—Sweating—Mesalazine—Crohn's disease	0.00417	0.00443	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00412	0.00437	CcSEcCtD
Cefuroxime—Sinusitis—Mesalazine—Crohn's disease	0.00408	0.00434	CcSEcCtD
Cefuroxime—Cefdinir—MPO—Crohn's disease	0.00407	0.0692	CrCbGaD
Cefuroxime—Agranulocytosis—Mesalazine—Crohn's disease	0.00406	0.00432	CcSEcCtD
Cefuroxime—Erythema multiforme—Azathioprine—Crohn's disease	0.00406	0.00431	CcSEcCtD
Cefuroxime—Body temperature increased—Mercaptopurine—Crohn's disease	0.00404	0.0043	CcSEcCtD
Cefuroxime—Cefaclor—MPO—Crohn's disease	0.00403	0.0686	CrCbGaD
Cefuroxime—Haemoglobin—Mesalazine—Crohn's disease	0.00393	0.00417	CcSEcCtD
Cefuroxime—Haemorrhage—Mesalazine—Crohn's disease	0.00391	0.00415	CcSEcCtD
Cefuroxime—Hepatitis—Mesalazine—Crohn's disease	0.00391	0.00415	CcSEcCtD
Cefuroxime—Immune system disorder—Azathioprine—Crohn's disease	0.00388	0.00412	CcSEcCtD
Cefuroxime—Urinary tract disorder—Mesalazine—Crohn's disease	0.00386	0.0041	CcSEcCtD
Cefuroxime—Chills—Azathioprine—Crohn's disease	0.00385	0.00409	CcSEcCtD
Cefuroxime—Urethral disorder—Mesalazine—Crohn's disease	0.00383	0.00407	CcSEcCtD
Cefuroxime—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00377	0.00401	CcSEcCtD
Cefuroxime—Erythema multiforme—Mesalazine—Crohn's disease	0.0037	0.00393	CcSEcCtD
Cefuroxime—Hyperkinesia—Prednisone—Crohn's disease	0.00359	0.00382	CcSEcCtD
Cefuroxime—Angiopathy—Mesalazine—Crohn's disease	0.00355	0.00377	CcSEcCtD
Cefuroxime—Immune system disorder—Mesalazine—Crohn's disease	0.00353	0.00375	CcSEcCtD
Cefuroxime—Chills—Mesalazine—Crohn's disease	0.00351	0.00373	CcSEcCtD
Cefuroxime—Diarrhoea—Mercaptopurine—Crohn's disease	0.0035	0.00372	CcSEcCtD
Cefuroxime—Thrombophlebitis—Prednisone—Crohn's disease	0.00345	0.00367	CcSEcCtD
Cefuroxime—Erythema—Mesalazine—Crohn's disease	0.0034	0.00362	CcSEcCtD
Cefuroxime—Flatulence—Mesalazine—Crohn's disease	0.00335	0.00356	CcSEcCtD
Cefuroxime—Leukopenia—Azathioprine—Crohn's disease	0.00334	0.00355	CcSEcCtD
Cefuroxime—Cefalotin—SLC22A5—Crohn's disease	0.00331	0.0563	CrCbGaD
Cefuroxime—Muscle spasms—Mesalazine—Crohn's disease	0.00327	0.00348	CcSEcCtD
Cefuroxime—Vomiting—Mercaptopurine—Crohn's disease	0.00325	0.00346	CcSEcCtD
Cefuroxime—Rash—Mercaptopurine—Crohn's disease	0.00323	0.00343	CcSEcCtD
Cefuroxime—Dermatitis—Mercaptopurine—Crohn's disease	0.00322	0.00342	CcSEcCtD
Cefuroxime—Arthralgia—Azathioprine—Crohn's disease	0.00318	0.00338	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00316	0.00336	CcSEcCtD
Cefuroxime—Angioedema—Mesalazine—Crohn's disease	0.00311	0.0033	CcSEcCtD
Cefuroxime—Leukopenia—Mesalazine—Crohn's disease	0.00305	0.00324	CcSEcCtD
Cefuroxime—Nausea—Mercaptopurine—Crohn's disease	0.00304	0.00323	CcSEcCtD
Cefuroxime—Cephalexin—SLC22A5—Crohn's disease	0.00301	0.0512	CrCbGaD
Cefuroxime—Palpitations—Mesalazine—Crohn's disease	0.00301	0.00319	CcSEcCtD
Cefuroxime—Thrombocytopenia—Azathioprine—Crohn's disease	0.00298	0.00317	CcSEcCtD
Cefuroxime—Cough—Mesalazine—Crohn's disease	0.00297	0.00315	CcSEcCtD
Cefuroxime—Skin disorder—Azathioprine—Crohn's disease	0.00296	0.00315	CcSEcCtD
Cefuroxime—Chest pain—Mesalazine—Crohn's disease	0.0029	0.00308	CcSEcCtD
Cefuroxime—Arthralgia—Mesalazine—Crohn's disease	0.0029	0.00308	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00288	0.00306	CcSEcCtD
Cefuroxime—Irritability—Prednisone—Crohn's disease	0.00285	0.00303	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00278	0.00295	CcSEcCtD
Cefuroxime—Anaphylactic shock—Mesalazine—Crohn's disease	0.00278	0.00295	CcSEcCtD
Cefuroxime—Thrombocytopenia—Mesalazine—Crohn's disease	0.00272	0.00289	CcSEcCtD
Cefuroxime—Tachycardia—Mesalazine—Crohn's disease	0.00271	0.00288	CcSEcCtD
Cefuroxime—Skin disorder—Mesalazine—Crohn's disease	0.0027	0.00287	CcSEcCtD
Cefuroxime—Hyperhidrosis—Mesalazine—Crohn's disease	0.00268	0.00285	CcSEcCtD
Cefuroxime—Anorexia—Mesalazine—Crohn's disease	0.00265	0.00281	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00263	0.0028	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00253	0.00269	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00249	0.00265	CcSEcCtD
Cefuroxime—Dyspnoea—Mesalazine—Crohn's disease	0.00248	0.00263	CcSEcCtD
Cefuroxime—Somnolence—Mesalazine—Crohn's disease	0.00247	0.00262	CcSEcCtD
Cefuroxime—Dyspepsia—Mesalazine—Crohn's disease	0.00244	0.0026	CcSEcCtD
Cefuroxime—Neutropenia—Prednisone—Crohn's disease	0.00242	0.00257	CcSEcCtD
Cefuroxime—Decreased appetite—Mesalazine—Crohn's disease	0.00241	0.00256	CcSEcCtD
Cefuroxime—Abdominal pain—Azathioprine—Crohn's disease	0.00241	0.00256	CcSEcCtD
Cefuroxime—Body temperature increased—Azathioprine—Crohn's disease	0.00241	0.00256	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.0024	0.00255	CcSEcCtD
Cefuroxime—Pain—Mesalazine—Crohn's disease	0.00237	0.00252	CcSEcCtD
Cefuroxime—Cefonicid—ALB—Crohn's disease	0.00229	0.0388	CrCbGaD
Cefuroxime—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00227	0.00241	CcSEcCtD
Cefuroxime—Hypersensitivity—Azathioprine—Crohn's disease	0.00225	0.00239	CcSEcCtD
Cefuroxime—Urticaria—Mesalazine—Crohn's disease	0.00221	0.00234	CcSEcCtD
Cefuroxime—Abdominal pain—Mesalazine—Crohn's disease	0.0022	0.00233	CcSEcCtD
Cefuroxime—Body temperature increased—Mesalazine—Crohn's disease	0.0022	0.00233	CcSEcCtD
Cefuroxime—Diarrhoea—Azathioprine—Crohn's disease	0.00209	0.00222	CcSEcCtD
Cefuroxime—Haemoglobin—Prednisone—Crohn's disease	0.00208	0.00221	CcSEcCtD
Cefuroxime—Haemorrhage—Prednisone—Crohn's disease	0.00207	0.0022	CcSEcCtD
Cefuroxime—Hypersensitivity—Mesalazine—Crohn's disease	0.00205	0.00217	CcSEcCtD
Cefuroxime—Dizziness—Azathioprine—Crohn's disease	0.00202	0.00214	CcSEcCtD
Cefuroxime—Pruritus—Mesalazine—Crohn's disease	0.00196	0.00209	CcSEcCtD
Cefuroxime—Vomiting—Azathioprine—Crohn's disease	0.00194	0.00206	CcSEcCtD
Cefuroxime—Rash—Azathioprine—Crohn's disease	0.00192	0.00204	CcSEcCtD
Cefuroxime—Dermatitis—Azathioprine—Crohn's disease	0.00192	0.00204	CcSEcCtD
Cefuroxime—Headache—Azathioprine—Crohn's disease	0.00191	0.00203	CcSEcCtD
Cefuroxime—Diarrhoea—Mesalazine—Crohn's disease	0.0019	0.00202	CcSEcCtD
Cefuroxime—Angiopathy—Prednisone—Crohn's disease	0.00188	0.00199	CcSEcCtD
Cefuroxime—Immune system disorder—Prednisone—Crohn's disease	0.00187	0.00198	CcSEcCtD
Cefuroxime—Dizziness—Mesalazine—Crohn's disease	0.00184	0.00195	CcSEcCtD
Cefuroxime—Nausea—Azathioprine—Crohn's disease	0.00181	0.00192	CcSEcCtD
Cefuroxime—Erythema—Prednisone—Crohn's disease	0.0018	0.00191	CcSEcCtD
Cefuroxime—Vomiting—Mesalazine—Crohn's disease	0.00177	0.00188	CcSEcCtD
Cefuroxime—Rash—Mesalazine—Crohn's disease	0.00175	0.00186	CcSEcCtD
Cefuroxime—Dermatitis—Mesalazine—Crohn's disease	0.00175	0.00186	CcSEcCtD
Cefuroxime—Headache—Mesalazine—Crohn's disease	0.00174	0.00185	CcSEcCtD
Cefuroxime—Agitation—Prednisone—Crohn's disease	0.00165	0.00176	CcSEcCtD
Cefuroxime—Nausea—Mesalazine—Crohn's disease	0.00165	0.00175	CcSEcCtD
Cefuroxime—Angioedema—Prednisone—Crohn's disease	0.00164	0.00175	CcSEcCtD
Cefuroxime—Convulsion—Prednisone—Crohn's disease	0.00156	0.00166	CcSEcCtD
Cefuroxime—Arthralgia—Prednisone—Crohn's disease	0.00153	0.00163	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00152	0.00162	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisone—Crohn's disease	0.00147	0.00156	CcSEcCtD
Cefuroxime—Tachycardia—Prednisone—Crohn's disease	0.00143	0.00152	CcSEcCtD
Cefuroxime—Skin disorder—Prednisone—Crohn's disease	0.00143	0.00152	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisone—Crohn's disease	0.00142	0.00151	CcSEcCtD
Cefuroxime—Anorexia—Prednisone—Crohn's disease	0.0014	0.00149	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00134	0.00142	CcSEcCtD
Cefuroxime—Dyspepsia—Prednisone—Crohn's disease	0.00129	0.00137	CcSEcCtD
Cefuroxime—Decreased appetite—Prednisone—Crohn's disease	0.00128	0.00136	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Prednisone—Crohn's disease	0.0012	0.00128	CcSEcCtD
Cefuroxime—Urticaria—Prednisone—Crohn's disease	0.00117	0.00124	CcSEcCtD
Cefuroxime—Abdominal pain—Prednisone—Crohn's disease	0.00116	0.00123	CcSEcCtD
Cefuroxime—Body temperature increased—Prednisone—Crohn's disease	0.00116	0.00123	CcSEcCtD
Cefuroxime—Cefazolin—ALB—Crohn's disease	0.00111	0.0188	CrCbGaD
Cefuroxime—Hypersensitivity—Prednisone—Crohn's disease	0.00108	0.00115	CcSEcCtD
Cefuroxime—Ceftriaxone—ALB—Crohn's disease	0.00105	0.0178	CrCbGaD
Cefuroxime—Pruritus—Prednisone—Crohn's disease	0.00104	0.0011	CcSEcCtD
Cefuroxime—Diarrhoea—Prednisone—Crohn's disease	0.00101	0.00107	CcSEcCtD
Cefuroxime—Dizziness—Prednisone—Crohn's disease	0.000972	0.00103	CcSEcCtD
Cefuroxime—Vomiting—Prednisone—Crohn's disease	0.000934	0.000992	CcSEcCtD
Cefuroxime—Rash—Prednisone—Crohn's disease	0.000926	0.000984	CcSEcCtD
Cefuroxime—Dermatitis—Prednisone—Crohn's disease	0.000925	0.000983	CcSEcCtD
Cefuroxime—Headache—Prednisone—Crohn's disease	0.00092	0.000978	CcSEcCtD
Cefuroxime—Cefalotin—ALB—Crohn's disease	0.000919	0.0156	CrCbGaD
Cefuroxime—Nausea—Prednisone—Crohn's disease	0.000873	0.000927	CcSEcCtD
Cefuroxime—Cephalexin—ALB—Crohn's disease	0.000836	0.0142	CrCbGaD
